Minimal influence of the menstrual cycle or hormonal contraceptives on performance in female rugby league athletes

Ella S. Smith,Jonathon Weakley,Alannah K. A. McKay,Rachel McCormick,Nicolin Tee,Megan A. Kuikman,Rachel Harris,Clare Minahan,Simon Buxton,Jessica Skinner,Kathryn E. Ackerman,Kirsty J. Elliott‐Sale,Trent Stellingwerff,Louise M. Burke
DOI: https://doi.org/10.1002/ejsc.12151
2024-06-16
European Journal of Sport Science
Abstract:We examined performance across one menstrual cycle (MC) and 3 weeks of hormonal contraceptives (HC) use to identify whether known fluctuations in estrogen and progesterone/progestin are associated with functional performance changes. National Rugby League Indigenous Women's Academy athletes [n = 11 naturally menstruating (NM), n = 13 using HC] completed performance tests [countermovement jump (CMJ), squat jump (SJ), isometric mid‐thigh pull, 20 m sprint, power pass and Stroop test] during three phases of a MC or three weeks of HC usage, confirmed through ovulation tests alongside serum estrogen and progesterone concentrations. MC phase or HC use did not influence jump height, peak force, sprint time, distance thrown or Stroop effect. However, there were small variations in kinetic and kinematic CMJ/SJ outputs. NM athletes produced greater mean concentric power in MC phase four than one [+0.41 W·kg−1 (+16.8%), p = 0.021] during the CMJ, alongside greater impulse at 50 ms at phase one than four [+1.7 N·s (+4.7%), p = 0.031] during the SJ, without differences between tests for HC users. Among NM athletes, estradiol negatively correlated with mean velocity and power (r = −0.44 to −0.50, p
sport sciences
What problem does this paper attempt to address?